Chai Discovery Series C Valuation Hits $3.8B in 2026 A 2026 analyst report on Chai Discovery's $400M Series C at a $3.8B valuation, covering Chai-3 benchmarks, Lilly, Pfizer, Novartis, and argenx deals, and AI drug discovery megaround trends.
Walking time: 7 hours
Charis Chambers, she explains whats currently known about GLP-1s and reproductive health, and how period tracking apps can be useful tools to help monitor any subtle hormonal changes
When a person has consumed a full meal 3060 minutes before their first drink, the pyloric valve is already in a state of managed closure, the stomach is processing macronutrients, and gastric ADH is active
Liraglutide: A review of the first once-daily GLP-1 receptor agonist
Becerra, the 24-year-old mentioned earlier, is passionate about optimizing men's hormones, as part of a bigger quest to boost testosterone, masculinity, and male self-confidence